CAN (SK): Canadian LP sucessfully sent tissue culture germplasm to South Africa

Mother Labs and Rascal Seed Research Laboratories have successfully shipped tissue culture germplasm to South Africa with Health Canada’s approval granted earlier this year. The companies have entered a long-term multi-year partnership whereby Mother Labs will supply contractual genetics, including more than ten (10) premium, high-quality cultivars to the South African Tissue Culture Laboratory and Research Facility.

Rascal Seed has selected premium genetics, cultivars that are 22-30% THC and +3% terpenes, and verified pest and pathogen-free, from Mother Lab’s curated inventory of plant material. In addition to this, Mother Labs’ expertise in dynamic supply and logistics supports Rascal Seeds’ research by ensuring that global air-freight shipments of these industry-shaping genetics arrive at the destination safely. Such relationships should help lead the way in the rapidly expanding market of medical cannabis in South Africa.

“For Rascal Seed, partnering with Mother Labs, an internationally recognized cannabis breeding and consulting company, for sourcing its genetics is a significant step towards starting in the direction of producing superior, consistent material, suitable for the medicinal cannabis industry. In partnership with Mother Labs and with our substantial experience in tissue culture technology and greenhouse cultivation, we also have plans to become an accredited source of reliable cannabis genetics in South Africa.” — Dawie Ras, Rascal Seed CEO.

"This successful shipment to South Africa signifies a new era in the international cannabis market. Mother Labs is excited to continue adding value to the international space by leveraging our extensive list of genetic offerings, our industry leading tissue culture lab, and the countless years of cannabis experience our team possesses. This is the first of many successful international deliveries.” — Brian Bain, Mother Labs CEO.

By providing trusted genetics, Mother Labs’ process of Biological Asset Management (BAM™) should help support cannabis reforms that are currently sweeping the continent of Africa, where the regulated cannabis industry is predicted to be worth as much as $7.1 billion by 2023.

For more information:
Mother Labs

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber